A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor

Clinical trial NCT06205082 · UNKNOWN

Trial details

NCT number: NCT06205082
Sponsor: LittDD Medicines Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2023-10-14
Primary completion: 2025-10-30
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.